India - HealthQuill

The WHO has issued a medical product alert on a contaminated cancer and autoimmune disease treatment drug made by Hyderabad, India-based Celon Laboratories, after Yemen and Lebanon raised concerns.

Yemen, Lebanon allege India’s Celon Labs’ drug ‘substandard’

The WHO has issued a medical product alert on a contaminated cancer and autoimmune disease treatment drug made by Hyderabad, India-based Celon Laboratories,.

by HealthQuill
March 28, 2023
0 Comments

A ransomware group has breached the information security network of India's Sun Pharmaceuticals unit, and there is a possibility that "file systems, business and personal data" might have been compromised.

Drugs Medical Pharma

Ransomware group behind cyberattack: Sun Pharma

A ransomware group has breached the information security network of India's Sun Pharmaceuticals unit, and there is a possibility that "file systems, business and personal.

by HealthQuill
March 27, 2023
0 Comments

The Indian government and the World Bank signed two agreements to support and enhance the development of the health sector in the south Asian nation.

Health Pharma

World Bank loans India $1 billion to aid healthcare sector

The Indian government and the World Bank signed two agreements to support and enhance the development of the health sector in the south.

by HealthQuill
March 4, 2023
0 Comments

India's WiproLab45 unveiled its Decentralized Identity and Credential Exchange (DICE) ID to put the user in control of their medical data, approval to share customer details, and enable citizens to claim government benefits.

Medical Pharma

Wipro unveils ‘tamper-proof’ self-verifiable digital wallet

India's WiproLab45 unveiled its Decentralized Identity and Credential Exchange (DICE) ID to put the user in control of their medical data, approval to.

by HealthQuill
February 22, 2023
0 Comments

blue light filtering not beneficial for eye health

Drugs Pharma

Global Pharma recalls eye drops after FDA contamination warning

India-based Global Pharma Healthcare voluntarily recalled all lots of its artificial tears lubricant eye drops after the USFDA reported possible contamination.

by HealthQuill
February 4, 2023
0 Comments

Max Healthcare, one of India’s largest private hospital chains, reported a 7% rise in profit after tax, on revenue of INR 15.6 billion, as average per occupied bed and international patient revenues jumped.

Drugs Medical Pharma

Max Healthcare profit jumps 7%, to raise INR 42 billion in debt

Max Healthcare, one of India’s largest private hospital chains, reported a 7% rise in profit after tax, on revenue of INR 15.6 billion,.

by HealthQuill
February 2, 2023
0 Comments

Stelis Biopharma, a division of India’s Strides Pharma Science, will become a full-fledged contract development and manufacturing firm and may list “near-term.

Drugs Health Pharma

Stelis Biopharma to be pure play CDMO firm, may list ‘near term’

Stelis Biopharma, a division of India’s Strides Pharma Science, will become a full-fledged contract development and manufacturing firm and may list “near-term.

by HealthQuill
February 1, 2023
0 Comments

Glenmark Pharmaceuticals, an Indian global drug maker with a focus on dermatology, respiratory and oncology areas, forecasts lifting of China's COVID-19 curbs may ease disruptions in the supply chain situation.

Drugs Medical Pharma

China’s lifting of COVID-19 curbs to ease supply chain disruptions: Glenmark

Glenmark Pharmaceuticals, an Indian global drug maker with a focus on dermatology, respiratory and oncology areas, forecasts lifting of China's COVID-19 curbs may.